Piramal Enterprises is looking to raise up to Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis. In this regard, a meeting of the administrative committee of the Board of Directors of the company will be held on July 21, 2016.
Piramal Enterprises is one of the leading players globally in CRAMS (custom research and manufacturing services) as well as in the critical care segment of inhalation and injectable anaesthetics. It also has a strong presence in the OTC segment in India.